Format

Send to

Choose Destination
BMJ Case Rep. 2017 May 13;2017. pii: bcr-2017-220351. doi: 10.1136/bcr-2017-220351.

Vedolizumab: a novel medical intervention in the treatment of primary sclerosing cholangitis.

Author information

1
Department of Internal Medicine, University of Florida, Gainesville, Florida, USA.
2
Department of Radiology, University of Florida College of Medicine, Gainesville, Florida, USA.
3
Department of Emergency Medicine, University of Florida College of Medicine, Gainesville, Florida, USA.
4
Department of Gastroenterology, University of Florida College of Medicine, Gainesville, Florida, USA.

KEYWORDS:

Biliary intervention; Gastrointestinal system; Inflammatory bowel disease; Liver disease

PMID:
28501828
DOI:
10.1136/bcr-2017-220351

Conflict of interest statement

Competing interests: None declared.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center